Brian Underdown
Board Director
Diabetes and endocrinology
enGene
Canada
Biography
Dr. Underdown is Managing Director of Lumira Capital, a later-stage venture capital company with investments in companies throughout North America. During his venture capital career, Dr. Underdown has been responsible for investments in life sciences companies at all stages of development with a particular focus on therapeutics. He had earlier been Assistant Vice-President for Research at Pasteur Merieux Connaught, where he headed the Canadian Universities Research program and several global programs to develop vaccines. During his academic career, he was Associate Dean of Research at the University of Toronto’s Faculty of Medicine and at McMaster University’s Faculty of Health Sciences. Dr. Underdown has held senior positions on national and international bodies concerned with science policy and university-industry collaboration.
Research Interest
He has served on boards of such life sciences companies as Argos Therapeutics, Ception Therapeutics, Cytochroma Inc., Golden Horseshoe Biotechnology Network, ID Biomedical, Nysa Membrane Technologies, Trillium Therapeutics, Transmolecular Therapeutics, and Viron Therapeutics. He received his PhD in Immunology from McGill University and undertook postdoctoral studies at Washington University School of Medicine in St. Louis.
